**Question:** Digitalis is used in the treatment of acute CHF. It can also be used as a long-term maintenance therapy if CHF is associated with:

**Correct Answer:** A. Coronary artery disease

**Core Concept:** Digitalis is a group of medications primarily used in the management of heart failure, particularly in patients with atrial fibrillation or flutter. It works by increasing the responsiveness of cardiac cells to calcium ions, leading to enhanced contractility and improved cardiac output. Digitalis has been traditionally used to treat congestive heart failure (CHF) by improving the filling of the heart chambers (ventricular filling) and reducing ventricular wall tension.

**Why the Correct Answer is Right:** Digitalis is often used in the management of CHF due to its beneficial effects on heart function. In patients with coronary artery disease (CAD), the presence of angina or myocardial infarction might lead to a reduced cardiac output and worsening CHF. In such cases, digitalis can improve cardiac output and alleviate the symptoms.

**Why Each Wrong Option is Incorrect:**

A. Coronary artery spasm (spontaneous vasospasm) is a rare cause of CHF. Digitalis would not be the primary treatment choice in this scenario since the issue lies with the coronary vasculature, not the heart muscle.

B. Digitalis may exacerbate arrhythmias or lead to electrolyte imbalances in some patients. As a result, it is not suitable for long-term maintenance therapy in patients with arrhythmias.

C. Digitalis is primarily used to treat heart rhythm disorders (arrhythmias) and not CHF. Its use in this context would be inappropriate and counterproductive.

D. Digitalis is often prescribed in the management of CHF, but it is not typically used as a long-term maintenance therapy for CHF. Instead, it is often used in conjunction with other medications and lifestyle modifications to manage CHF.

**Clinical Pearl:** While digitalis is a valuable tool in managing CHF, its use should be carefully tailored to the specific patient scenario. In cases of CHF associated with coronary artery disease, digitalis may be a suitable choice due to its effect on cardiac output. However, other medications and interventions should also be considered based on the individual patient's condition.